Transparency Market Research (TMR) has published a new report titled, “Kidney Dialysis Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global kidney dialysis equipment market was valued at US$ 14,673.3 Mn in 2017 is projected to expand at a CAGR of 5.2% from 2018 to 2026. Increase in incidence of CKD & ESRD, rise in awareness about dialysis at home, surge in geriatric population, and technological advancements are major factors that are anticipated to fuel the market from 2018 to 2026. Improved hospital infrastructure in developed regions such as North America and Europe, rising investments by key players in Asia Pacific are key factors that are projected to drive the market during the forecast period.
Request a Sample of Kidney Dialysis Equipment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39359
Increase in Hemodialysis Centers by Market Players to Boost the In-Center Dialysis Center Segment
Increase in the number of hemodialysis centers by key players, such as Fresenius Kabi, has increased the availability of dialysis treatment at an affordable cost. In the U.S., Fresenius Kabi had more than 2,200 dialysis clinics in 2017, approximately treating 192,964 patients. Fresenius Kabi conducts 575,000 dialysis treatment on approximately 4000 patients every year. Fresenius Kabi has more than 50 dialysis centers across England and Wales.
Rise in Incidence of Chronic Kidney Disease (CKD) & End Stage Renal Disease (ESRD) to Propel the Market
CKD is a major risk factor for cardiovascular disease, diabetes, hypertension, glomerulonephritis, and aging. CKD may lead to kidney injury and sometimes complete loss of kidney function, thus requiring renal replacement therapy. In 2016, on the occasion of World Kidney Day, a global awareness campaign, estimated that 10% of the worldwide population is affected by CKD. According to the Global Burden of Diseases Study, CKD stood 18th in the global list of causes of total number of deaths in 2010. CKD leads to end-stage renal disease (ESRD), if untreated. The National Kidney Foundation estimated that, in 2015, about 660,000 individuals were suffering from CKD and 468,000 ESRD patients were on dialysis in the U.S. alone. Thus, easy availability of dialysis for kidney disease and high global prevalence of CKD are major factors driving the dialysis equipment market. According to the European Renal Care Providers Association, in 2015, out of 3.2 million patients treated for ESRD, about 2.5 million people underwent dialysis, while 678,000 were living with transplants.
Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39359
High Cost of Dialysis and Implantable Artificial Kidney to Restrain Market
The WHO states that the general availability of kidney dialysis is reported by 60% of countries worldwide. Its availability is 93% in high-income countries (53 countries). In developing and under-developed countries, the availability is 46% and 27%, respectively. The World Kidney Day campaign states that in developing countries, about one million people die annually due to unaffordable renal replacement. In several countries in Asia, only 10% of the population receives renal replacement therapy and hence, several die without receiving any treatment. Therefore, the high cost of dialysis equipment and services is a major restraint for the kidney dialysis equipment market. The University of San Francisco, California, and Cleveland Clinic initiated the ‘Kidney Project’ in order to build a surgically implantable artificial kidney, known as ‘Cyborg Kidney’. In 2012, the project received fast-track FDA approval and is soliciting active funding. The project is not only a treatment but a cure for millions with CKD. In November 2015, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) offered this project a grant of US$ 6 Mn. Clinical trials for the project are expected to be completed by 2020.
Request for Analysis of COVID19 Impact on Kidney Dialysis Equipment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39359
Market in Asia Pacific to Witness Exponential Growth
In terms of revenue, the kidney dialysis equipment market in Asia Pacific is expected to expand at a CAGR of 6.1% during the forecast period. According to NCBI, in 2016, it is estimated that approximately 17% of the population in Asia Pacific was suffering from CKD, and increasing investment of key players such as Fresenius Kabi and Baxter International in the market in Asia Pacific market is a key factor boosting the kidney dialysis equipment market in the region.
Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, NxStage Medical, Inc. and Asahi Kasei Corporation to Lead the Market
Purchase Kidney Dialysis Equipment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=39359<ype=S
The report also provides profiles of leading players operating in the global kidney dialysis equipment market such as Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, NxStage Medical, Inc., Asahi Kasei Corporation, Nipro Corporation, Terumo Corporation, Rockwell Medical, Teleflex Incorporated, and HEMOCLEAN CO., LTD.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Read More Reports: https://www.prnewswire.com/news-releases/robust-drugs-pipeline-to-underscore-growth-in-life-sciences-bpo-market-transparency-market-research-301032396.html